In the latest session, Emergent Biosolutions Inc (NYSE: EBS) closed at $2.53 down -2.32% from its previous closing price of $2.59. In other words, the price has decreased by -$0.0600 from its previous closing price. On the day, 1088975 shares were traded. EBS stock price reached its highest trading level at $2.7180 during the session, while it also had its lowest trading level at $2.4500.
Ratios:
For a deeper understanding of Emergent Biosolutions Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.54 and its Current Ratio is at 1.04. In the meantime, Its Debt-to-Equity ratio is 1.35 whereas as Long-Term Debt/Eq ratio is at 0.71.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Jun 02 ’23 when Zoon Kathryn C sold 1,830 shares for $8.35 per share. The transaction valued at 15,280 led to the insider holds 49,971 shares of the business.
Zoon Kathryn C sold 1,700 shares of EBS for $14,246 on May 25 ’23. The Director now owns 51,801 shares after completing the transaction at $8.38 per share.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, EBS now has a Market Capitalization of 132.07M and an Enterprise Value of 880.57M. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.13 while its Price-to-Book (P/B) ratio in mrq is 0.20. Its current Enterprise Value per Revenue stands at 0.86 whereas that against EBITDA is -1.70.
Stock Price History:
The Beta on a monthly basis for EBS is 1.20, which has changed by -74.16% over the last 52 weeks, in comparison to a change of 27.39% over the same period for the S&P500. Over the past 52 weeks, EBS has reached a high of $13.67, while it has fallen to a 52-week low of $1.42. The 50-Day Moving Average of the stock is 2.2698, while the 200-Day Moving Average is calculated to be 3.7290.
Shares Statistics:
For the past three months, EBS has traded an average of 3.09M shares per day and 1.43M over the past ten days. A total of 52.20M shares are outstanding, with a floating share count of 50.07M. Insiders hold about 4.08% of the company’s shares, while institutions hold 78.64% stake in the company. Shares short for EBS as of Mar 15, 2024 were 4.91M with a Short Ratio of 1.59, compared to 11.54M on Feb 15, 2024. Therefore, it implies a Short% of Shares Outstanding of 9.41% and a Short% of Float of 15.53%.
Earnings Estimates
There are 1 different market analysts currently analyzing its stock. On average, analysts expect EPS of -$0.83 for the current quarter, with a high estimate of -$0.83 and a low estimate of -$0.83, while EPS last year was -$3.17. The consensus estimate for the next quarter is -$0.63, with high estimates of -$0.63 and low estimates of -$0.63.
Analysts are recommending an EPS of between -$2 and -$2 for the fiscal current year, implying an average EPS of -$2. EPS for the following year is $3.67, with 1 analysts recommending between $3.67 and $3.67.
Revenue Estimates
A total of 1 analysts have provided revenue estimates for EBS’s current fiscal year. The highest revenue estimate was $1.02B, while the lowest revenue estimate was $1.02B, resulting in an average revenue estimate of $1.02B. In the same quarter a year ago, actual revenue was $1.05B, down -2.30% from the average estimate. Based on 1 analysts’ estimates, the company’s revenue will be $1.13B in the next fiscal year. The high estimate is $1.13B and the low estimate is $1.13B. The average revenue growth estimate for next year is up 9.90% from the average revenue estimate for this year.
